Growth Metrics

Trinity Biotech (TRIB) Equity Average (2021 - 2022)

Trinity Biotech's Equity Average history spans 2 years, with the latest figure at $2.2 million for Q4 2022.

  • On a quarterly basis, Equity Average rose 807.74% to $2.2 million in Q4 2022 year-over-year; TTM through Dec 2022 was $2.2 million, a 807.74% increase, with the full-year FY2025 number at -$53.6 million, down 81.23% from a year prior.
  • Equity Average hit $2.2 million in Q4 2022 for Trinity Biotech, down from $11.2 million in the prior quarter.
  • Over the last five years, Equity Average for TRIB hit a ceiling of $11.2 million in Q3 2022 and a floor of -$3.3 million in Q1 2022.